DE60143889D1 - Parasiticide formulierung und methode zur herstellung dieser formulierung - Google Patents

Parasiticide formulierung und methode zur herstellung dieser formulierung

Info

Publication number
DE60143889D1
DE60143889D1 DE60143889T DE60143889T DE60143889D1 DE 60143889 D1 DE60143889 D1 DE 60143889D1 DE 60143889 T DE60143889 T DE 60143889T DE 60143889 T DE60143889 T DE 60143889T DE 60143889 D1 DE60143889 D1 DE 60143889D1
Authority
DE
Germany
Prior art keywords
formulation
parasiticidal
solvent
animal
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60143889T
Other languages
English (en)
Inventor
Richard Mihalik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Healthcare Animal Health Inc
Original Assignee
Teva Animal Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Animal Health Inc filed Critical Teva Animal Health Inc
Application granted granted Critical
Publication of DE60143889D1 publication Critical patent/DE60143889D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DE60143889T 2000-02-16 2001-02-12 Parasiticide formulierung und methode zur herstellung dieser formulierung Expired - Lifetime DE60143889D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/504,830 US6340672B1 (en) 2000-02-16 2000-02-16 Parasiticidal formulation and a method of making this formulation
PCT/US2001/004538 WO2001060380A1 (en) 2000-02-16 2001-02-12 A parasiticidal formulation and a method of making this formulation

Publications (1)

Publication Number Publication Date
DE60143889D1 true DE60143889D1 (de) 2011-03-03

Family

ID=24007921

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60143889T Expired - Lifetime DE60143889D1 (de) 2000-02-16 2001-02-12 Parasiticide formulierung und methode zur herstellung dieser formulierung

Country Status (8)

Country Link
US (2) US6340672B1 (de)
EP (1) EP1299108B1 (de)
AT (1) ATE495748T1 (de)
AU (3) AU2001236949B2 (de)
DE (1) DE60143889D1 (de)
DK (1) DK1299108T3 (de)
ES (1) ES2357697T3 (de)
WO (1) WO2001060380A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ335166A (en) * 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
DE60118132T2 (de) * 2000-10-10 2006-10-19 Wyeth Anthelmintika
US6893652B2 (en) * 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
GB2386066A (en) 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
KR100600402B1 (ko) * 2002-05-22 2006-07-14 주식회사 엘지생명과학 피부 도포용 이버멕틴 조성물 및 그 제조방법
US20060205681A1 (en) * 2002-06-21 2006-09-14 Maryam Moaddeb Homogenous paste formulations
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
NZ520295A (en) * 2002-07-19 2005-04-29 Ashmont Holdings Ltd Anthelmintic formulations comprising levamisole and either an avermectin or milbemycin
AU2006100530B4 (en) * 2002-07-19 2006-08-03 Merial Ltd Levamisole, Avermectins or similsr in pyrrolidone solvent
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
AU2003284802A1 (en) * 2002-11-27 2004-06-18 Eco Animal Health Ltd An injection of animal remedy including closantel or closantel sodium
AU2012200544C1 (en) * 2003-02-05 2017-06-29 Jurox Pty Ltd Anthelmintic composition
AU2003900505A0 (en) * 2003-02-05 2003-02-20 Jurox Pty Ltd Anthelmintic composition
UA82359C2 (uk) * 2003-04-03 2008-04-10 Schering Plough Ltd Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин
ES2620413T3 (es) * 2003-04-04 2017-06-28 Merial Ltd. Formulaciones veterinarias antihelmínticas tópicas
GB0316377D0 (en) * 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
US7666444B2 (en) * 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
AU2005210632B2 (en) * 2004-02-03 2011-02-03 Zoetis Services Llc Anthelmintic composition
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
KR20070008686A (ko) * 2004-04-07 2007-01-17 인터벳 인터내셔널 비.브이. 벤지미다졸, 아버멕틴 및 프라지콴텔의 효능성 조성물 및이의 사용 방법
US20060014641A1 (en) * 2004-07-13 2006-01-19 Zaghmout Ousama M Pathogen control with an oxalate (oxalic acid)
WO2006036624A2 (en) * 2004-09-24 2006-04-06 The Hartz Mountain Corporation Lipid stabilized formulations
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
ES2366109T3 (es) 2005-09-15 2011-10-17 Merial Limited Formulaciones antihelmínticas.
GB0525093D0 (en) * 2005-12-09 2006-01-18 Norbrook Lab Ltd Veterinary composition
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
EP1849363A1 (de) * 2006-03-09 2007-10-31 Cheminova A/S Synergistische Kombinationen aus Glutaminsäure- und GABA-aktivierten Chloridkanälen agonistischen Pestiziden und mindestens eins von Vitamin E und Niacin
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
AU2013201461B2 (en) * 2007-11-26 2015-10-29 Boehringer Ingelheim Animal Health USA Inc. Solvent systems for pour-on formulations for combating parasites
NZ585499A (en) * 2007-11-26 2011-12-22 Merial Ltd Solvent systems for pour-on formulations for combating parasites
PT2331068T (pt) * 2008-10-08 2017-03-13 Zoetis Services Llc Composições anti-helmínticas de benzimidazol
GB0905365D0 (en) * 2009-03-27 2009-05-13 Norbrook Lab Ltd A topical parasiticide composition
US20120129801A1 (en) * 2009-05-01 2012-05-24 Wyeth Llc Blood parasiticide
NZ594610A (en) 2011-08-16 2013-03-28 Virbac New Zealand Ltd Injectable Anthelmintic Formulations cotaining levamisole and one or more macrocyclic lactones for controlling internal parasites in ruminants
AU2013201479C1 (en) 2012-03-13 2017-11-09 Elanco New Zealand Long Acting Compositions
AU2013245011B2 (en) * 2012-04-04 2017-11-23 Intervet International B.V. Solid oral pharmaceutical compositions for isoxazoline compounds
FR2991173B1 (fr) * 2012-06-04 2015-11-06 Virbac Composition veterinaire a administration cutanee a base d'oxyclozanide
WO2017083422A1 (en) * 2015-11-09 2017-05-18 Momeni Ali Sensor system for collecting gestural data in two-dimensional animation
CN108653309A (zh) * 2018-05-09 2018-10-16 福建省农业科学院 一种发酵床大栏养猪驱虫方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1194791A (en) * 1981-05-08 1985-10-08 John M. Ballany Parasiticidal pour-on compositions
AU1611383A (en) * 1982-07-02 1984-01-05 Robert Young & Company Limited Pesticidal formulation with cypermethrin
RU2097043C1 (ru) 1994-09-16 1997-11-27 Акционерное общество "Ветеринарные препараты" Акарицидный препарат биорекс
US6193989B1 (en) * 1997-03-21 2001-02-27 Biogenesis S.A. Long acting injectable parasiticidal composition and the process for its preparation
US6054140A (en) * 1997-03-21 2000-04-25 Biogenesis S.A. Long acting injectable parasiticidal composition and the process for its preparation
EE04216B1 (et) * 1998-03-19 2004-02-16 Merck & Co., Inc. Vedel polümeerne kompositsioon ning selle kasutamine ravimina, mis on ette nähtud hüdrofoobse bioaktiivse aine reguleeritud vabastamiseks loomorganismis

Also Published As

Publication number Publication date
AU2006236097A1 (en) 2006-12-07
DK1299108T3 (da) 2011-04-11
EP1299108A1 (de) 2003-04-09
AU3694901A (en) 2001-08-27
US6340672B1 (en) 2002-01-22
WO2001060380A1 (en) 2001-08-23
EP1299108B1 (de) 2011-01-19
US6492340B2 (en) 2002-12-10
ES2357697T3 (es) 2011-04-28
EP1299108A4 (de) 2007-05-30
ATE495748T1 (de) 2011-02-15
AU2001236949B2 (en) 2006-08-17
US20020010142A1 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
DE60143889D1 (de) Parasiticide formulierung und methode zur herstellung dieser formulierung
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
ECSP034883A (es) Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que las contienen
ATE314092T1 (de) Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
DE69919863T8 (de) Stabilgelmischung in form einer mischung eines öligen gels und eines wässrigen gels
BR0215052A (pt) Composições acaricidas e métodos
ATE267798T1 (de) Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
DE60134245D1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
AR034881A1 (es) Mezcla insecticida
ATE222759T1 (de) Tranilast enthaltendes externum und verfahren zu dessen herstellung
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
ATE324907T1 (de) Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
IL139230A0 (en) Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds to the upper respiratory tract and/or the ear
BR0007147A (pt) Composição de tensìdio contendo tensìdio gemini e co-anfifila, sua preparação e aplicação
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
ATE279910T1 (de) Tensid für äusserlich anzuwendende hautpräparate und diese beinhaltende äusserlich anzuwendende hautpräparate
DE69821655D1 (de) Verwendung von phospholipiden zur herstellung eines arzneimittels zur vorbeugung von adhäsionen
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
BR0010983A (pt) Preparações para a aplicação de agentes antiinflamatórios
BRPI0411832A (pt) forma de administração em forma de pelìcula para a administração transmucosa de substáncias ativas, uso da forma de administração e processo para a produção de uma forma de administração
PT1305057E (pt) Composicao de biomateria microparticular para uso medicinal
DE69808938D1 (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
ATE458471T1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
DE69711588D1 (de) Nimesulid enthaltende pharmazeutische zubereitung zur topischen anwendung